Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Chemical Name : (2S) -2- Amino-4-[1- (carboxymethyl) carbamoyl-(2R)-2-sulfanylethylcarbamoyl] butanoic acid
(2018) 175:13361351.e1317
Retatrutide is an investigational triple receptor agonist being studied for its effects on appetite control, metabolism and energy balance
The FDA approval is currently for adults with: A body mass index (BMI) of 30 or greater (obesity), or A BMI of 27 or greater (overweight) with at least one weight-related condition such as type 2 diabetes, high blood pressure, or high cholesterol The pill is not currently approved for type 1 diabetes (T1D) management, and the OASIS 4 trial excluded people with type 2 diabetes though that research is ongoing
US$ 20.95
US$ 27.82
US$ 28.72
